# CARRIER GLOBAL Corp: financial statements, quarterly CARR · NYSE · CIK 1783180 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/carr.md) · [Financials](/companies/carr/financials.md) · [Filings](/companies/carr/filings.md) · [Insiders](/companies/carr/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/carr/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [4,316](/filings/0001783180-25-000008.md) | [5,420](/filings/0001783180-25-000030.md) | [5,934](/filings/0001783180-25-000052.md) | [5,984](/filings/0001783180-25-000066.md) | [5,148](/filings/0001783180-25-000008.md) | [5,218](/filings/0001783180-26-000026.md) | [6,113](/filings/0001783180-26-000032.md) | [5,579](/filings/0001783180-26-000037.md) | [4,837 d](/filings/0001783180-26-000008.md) | [5,341](/filings/0001783180-26-000026.md) | [6,351](/filings/0001783180-26-000032.md) | [6,263](/filings/0001783180-26-000037.md) | | Research and development | $m | [138 d](/filings/0001783180-26-000008.md) | [192](/filings/0001783180-25-000030.md) | [160](/filings/0001783180-25-000052.md) | [172](/filings/0001783180-25-000066.md) | [162 d](/filings/0001783180-26-000008.md) | [153](/filings/0001783180-26-000026.md) | [161](/filings/0001783180-26-000032.md) | [151](/filings/0001783180-26-000037.md) | [160 d](/filings/0001783180-26-000008.md) | [143](/filings/0001783180-26-000026.md) | [148](/filings/0001783180-26-000032.md) | [154](/filings/0001783180-26-000037.md) | | Selling, general and administrative | $m | [737 d](/filings/0001783180-26-000008.md) | [807](/filings/0001783180-25-000030.md) | [789](/filings/0001783180-25-000052.md) | [799](/filings/0001783180-25-000066.md) | [803 d](/filings/0001783180-26-000008.md) | [729](/filings/0001783180-26-000026.md) | [813](/filings/0001783180-26-000032.md) | [803](/filings/0001783180-26-000037.md) | [747 d](/filings/0001783180-26-000008.md) | [861](/filings/0001783180-26-000026.md) | [810](/filings/0001783180-26-000032.md) | [758](/filings/0001783180-26-000037.md) | | Operating income | $m | [539](/filings/0001783180-25-000008.md) | [385](/filings/0001783180-25-000030.md) | [724](/filings/0001783180-25-000052.md) | [763](/filings/0001783180-25-000066.md) | [774](/filings/0001783180-25-000008.md) | [629](/filings/0001783180-26-000026.md) | [903](/filings/0001783180-26-000032.md) | [539](/filings/0001783180-26-000037.md) | [101 d](/filings/0001783180-26-000008.md) | [259](/filings/0001783180-26-000026.md) | [825](/filings/0001783180-26-000032.md) | [(2,273)](/filings/0001783180-26-000037.md) | | Income tax | $m | [68.0 d](/filings/0001783180-26-000008.md) | [47.0](/filings/0001783180-25-000030.md) | [120](/filings/0001783180-25-000052.md) | [172](/filings/0001783180-25-000066.md) | [723 d](/filings/0001783180-26-000008.md) | [111](/filings/0001783180-26-000026.md) | [162](/filings/0001783180-26-000032.md) | [(1.0)](/filings/0001783180-26-000037.md) | [(32.0) d](/filings/0001783180-26-000008.md) | [(96.0)](/filings/0001783180-26-000026.md) | [180](/filings/0001783180-26-000032.md) | [177](/filings/0001783180-26-000037.md) | | Net income | $m | [420 d](/filings/0001783180-26-000008.md) | [269](/filings/0001783180-25-000030.md) | [2,337](/filings/0001783180-25-000052.md) | [447](/filings/0001783180-25-000066.md) | [2,551 d](/filings/0001783180-26-000008.md) | [412](/filings/0001783180-26-000026.md) | [591](/filings/0001783180-26-000032.md) | [428](/filings/0001783180-26-000037.md) | [53.0 d](/filings/0001783180-26-000008.md) | [238](/filings/0001783180-26-000026.md) | [501](/filings/0001783180-26-000032.md) | [(2,593)](/filings/0001783180-26-000037.md) | | Diluted EPS | $ per share | not reported | [0.29](/filings/0001783180-25-000030.md) | [2.55](/filings/0001783180-25-000052.md) | [0.49](/filings/0001783180-25-000066.md) | not reported | [0.47](/filings/0001783180-26-000026.md) | [0.68](/filings/0001783180-26-000032.md) | [0.50](/filings/0001783180-26-000037.md) | not reported | [0.28](/filings/0001783180-26-000026.md) | [0.60](/filings/0001783180-26-000032.md) | [(3.16)](/filings/0001783180-26-000037.md) | | Basic EPS | $ per share | not reported | [0.30](/filings/0001783180-25-000030.md) | [2.59](/filings/0001783180-25-000052.md) | [0.50](/filings/0001783180-25-000066.md) | not reported | [0.47](/filings/0001783180-26-000026.md) | [0.69](/filings/0001783180-26-000032.md) | [0.50](/filings/0001783180-26-000037.md) | not reported | [0.29](/filings/0001783180-26-000026.md) | [0.61](/filings/0001783180-26-000032.md) | [(3.16)](/filings/0001783180-26-000037.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [9.9](/filings/0001783180-26-000008.md) | [1.2](/filings/0001783180-25-000030.md) | [2.8](/filings/0001783180-25-000052.md) | [2.2](/filings/0001783180-25-000066.md) | [4.0](/filings/0001783180-26-000008.md) | [1.7](/filings/0001783180-26-000026.md) | [1.8](/filings/0001783180-26-000032.md) | [1.4](/filings/0001783180-26-000037.md) | [1.6](/filings/0001783180-26-000037.md) | [1.4](/filings/0001783180-26-000026.md) | [1.3](/filings/0001783180-26-000032.md) | [1.4](/filings/0001783180-26-000037.md) | | Current assets | $bn | [19.6](/filings/0001783180-25-000008.md) | [11.7](/filings/0001783180-24-000044.md) | [11.6](/filings/0001783180-24-000077.md) | [11.2](/filings/0001783180-24-000088.md) | [9.9](/filings/0001783180-26-000008.md) | [8.4](/filings/0001783180-25-000030.md) | [9.1](/filings/0001783180-25-000052.md) | [8.8](/filings/0001783180-25-000066.md) | [8.5](/filings/0001783180-26-000037.md) | [9.0](/filings/0001783180-26-000026.md) | [9.4](/filings/0001783180-26-000032.md) | [8.9](/filings/0001783180-26-000037.md) | | Total assets | $bn | [32.8](/filings/0001783180-25-000008.md) | [40.8](/filings/0001783180-24-000044.md) | [40.4](/filings/0001783180-24-000077.md) | [40.2](/filings/0001783180-24-000088.md) | [37.4](/filings/0001783180-26-000008.md) | [36.4](/filings/0001783180-25-000030.md) | [38.5](/filings/0001783180-25-000052.md) | [38.1](/filings/0001783180-25-000066.md) | [37.2](/filings/0001783180-26-000037.md) | [37.2](/filings/0001783180-26-000026.md) | [37.4](/filings/0001783180-26-000032.md) | [33.6](/filings/0001783180-26-000037.md) | | Current liabilities | $bn | [7.0](/filings/0001783180-25-000008.md) | [8.6](/filings/0001783180-24-000044.md) | [10.7](/filings/0001783180-24-000077.md) | [10.4](/filings/0001783180-24-000088.md) | [7.9](/filings/0001783180-26-000008.md) | [7.0](/filings/0001783180-25-000030.md) | [7.8](/filings/0001783180-25-000052.md) | [7.7](/filings/0001783180-25-000066.md) | [7.1](/filings/0001783180-26-000037.md) | [8.6](/filings/0001783180-26-000026.md) | [9.2](/filings/0001783180-26-000032.md) | [8.9](/filings/0001783180-26-000037.md) | | Total liabilities | $bn | [23.8](/filings/0001783180-25-000008.md) | [28.9](/filings/0001783180-24-000044.md) | [26.3](/filings/0001783180-24-000077.md) | [25.2](/filings/0001783180-24-000088.md) | [23.0](/filings/0001783180-26-000008.md) | [22.2](/filings/0001783180-25-000030.md) | [23.5](/filings/0001783180-25-000052.md) | [23.2](/filings/0001783180-25-000066.md) | [23.1](/filings/0001783180-26-000037.md) | [23.4](/filings/0001783180-26-000026.md) | [23.9](/filings/0001783180-26-000032.md) | [23.2](/filings/0001783180-26-000037.md) | | Long-term debt | $bn | [14.2](/filings/0001783180-24-000088.md) | [15.6](/filings/0001783180-24-000044.md) | [11.3](/filings/0001783180-24-000077.md) | [10.3](/filings/0001783180-24-000088.md) | [11.0](/filings/0001783180-26-000008.md) | [11.1](/filings/0001783180-25-000030.md) | [11.3](/filings/0001783180-25-000052.md) | [11.3](/filings/0001783180-25-000066.md) | [11.4](/filings/0001783180-26-000037.md) | [10.4](/filings/0001783180-26-000026.md) | [10.3](/filings/0001783180-26-000032.md) | [10.0](/filings/0001783180-26-000037.md) | | Current portion of debt | $bn | [0.1](/filings/0001783180-25-000008.md) | [1.2](/filings/0001783180-24-000044.md) | [2.1](/filings/0001783180-24-000077.md) | [2.1](/filings/0001783180-24-000088.md) | [1.3](/filings/0001783180-26-000008.md) | [0.1](/filings/0001783180-25-000030.md) | [0.1](/filings/0001783180-25-000052.md) | [0.1](/filings/0001783180-25-000066.md) | [0.1](/filings/0001783180-26-000037.md) | [1.0](/filings/0001783180-26-000026.md) | [0.9](/filings/0001783180-26-000032.md) | [1.3](/filings/0001783180-26-000037.md) | | Short-term borrowings | $bn | not reported | not reported | not reported | not reported | [0.0](/filings/0001783180-26-000008.md) | not reported | not reported | [0.4](/filings/0001783180-25-000066.md) | [0.3](/filings/0001783180-26-000037.md) | [0.7](/filings/0001783180-26-000026.md) | [0.7](/filings/0001783180-26-000032.md) | [0.2](/filings/0001783180-26-000037.md) | | Shareholders' equity | $bn | [9.0](/filings/0001783180-26-000008.md) | [11.9](/filings/0001783180-25-000066.md) | [14.1](/filings/0001783180-25-000066.md) | [15.0](/filings/0001783180-25-000066.md) | [14.4](/filings/0001783180-26-000037.md) | [14.2](/filings/0001783180-26-000037.md) | [15.0](/filings/0001783180-26-000037.md) | [14.8](/filings/0001783180-26-000037.md) | [14.1](/filings/0001783180-26-000037.md) | [13.8](/filings/0001783180-26-000037.md) | [13.5](/filings/0001783180-26-000037.md) | [10.4](/filings/0001783180-26-000037.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: us-gaap:CommercialPaper - Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ## Cash flow | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [1,062 d](/filings/0001783180-26-000008.md) | [40.0](/filings/0001783180-25-000030.md) | [660 d](/filings/0001783180-25-000052.md) | [(269) d](/filings/0001783180-25-000066.md) | [132 d](/filings/0001783180-26-000008.md) | [483](/filings/0001783180-26-000026.md) | [649 d](/filings/0001783180-26-000032.md) | [341 d](/filings/0001783180-26-000037.md) | [1,040 d](/filings/0001783180-26-000008.md) | [79.0](/filings/0001783180-26-000026.md) | [927 d](/filings/0001783180-26-000032.md) | [813 d](/filings/0001783180-26-000037.md) | | Capital expenditure | $m | [222 d](/filings/0001783180-26-000008.md) | [102](/filings/0001783180-25-000030.md) | [108 d](/filings/0001783180-25-000052.md) | [92.0 d](/filings/0001783180-25-000066.md) | [217 d](/filings/0001783180-26-000008.md) | [63.0](/filings/0001783180-26-000026.md) | [81.0 d](/filings/0001783180-26-000032.md) | [117 d](/filings/0001783180-26-000037.md) | [131 d](/filings/0001783180-26-000008.md) | [94.0](/filings/0001783180-26-000026.md) | [117 d](/filings/0001783180-26-000032.md) | [139 d](/filings/0001783180-26-000037.md) | | Dividends paid | $m | [155 d](/filings/0001783180-26-000008.md) | [159](/filings/0001783180-25-000030.md) | [171 d](/filings/0001783180-25-000052.md) | [184 d](/filings/0001783180-25-000066.md) | [156 d](/filings/0001783180-26-000008.md) | [198](/filings/0001783180-26-000026.md) | [192 d](/filings/0001783180-26-000032.md) | [193 d](/filings/0001783180-26-000037.md) | [189 d](/filings/0001783180-26-000008.md) | [201](/filings/0001783180-26-000026.md) | [199 d](/filings/0001783180-26-000032.md) | [198 d](/filings/0001783180-26-000037.md) | | Share repurchases | $m | [0.0 d](/filings/0001783180-26-000008.md) | [0.0](/filings/0001783180-25-000030.md) | [0.0 d](/filings/0001783180-25-000052.md) | [431 d](/filings/0001783180-25-000066.md) | [1,513 d](/filings/0001783180-26-000008.md) | [1,288](/filings/0001783180-26-000026.md) | [340 d](/filings/0001783180-26-000032.md) | [785 d](/filings/0001783180-26-000037.md) | [479 d](/filings/0001783180-26-000008.md) | [306](/filings/0001783180-26-000026.md) | [439 d](/filings/0001783180-26-000032.md) | [399 d](/filings/0001783180-26-000037.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [852](/filings/0001783180-24-000044.md) | [851](/filings/0001783180-24-000077.md) | [855](/filings/0001783180-24-000088.md) | [913](/filings/0001783180-25-000030.md) | [915](/filings/0001783180-25-000052.md) | [915](/filings/0001783180-25-000066.md) | [878](/filings/0001783180-26-000026.md) | [866](/filings/0001783180-26-000032.md) | [859](/filings/0001783180-26-000037.md) | [843](/filings/0001783180-26-000026.md) | [837](/filings/0001783180-26-000032.md) | [822](/filings/0001783180-26-000037.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 818,160,206 at 2026-10-15, from the cover of the [10-Q filed 2026-10-29](/filings/0001783180-26-000037.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 14:51 ET. No prices; not investment advice.